1 / 29

National Cancer Peer Review Programme

National Cancer Peer Review Programme. Ruth Bridgeman National Programme Director . The Future of Peer Review. It has now been confirm that the peer review programme will move to the NHS Commissioning Board’s (NHS CB) Improvement Body as part of the Transitional Delivery Partner.

millicent
Télécharger la présentation

National Cancer Peer Review Programme

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. National Cancer Peer Review Programme Ruth Bridgeman National Programme Director

  2. The Future of Peer Review It has now been confirm that the peer review programme will move to the NHS Commissioning Board’s (NHS CB) Improvement Body as part of the Transitional Delivery Partner. In discussions about peer review: • There is positive support to retain the programme • However a long term host has not been agreed • It is agreed it will be hosted by the Improvement Body until a suitable host is found.

  3. The 2012/2013 Peer Review Cycle How we will manage the position with networks? • The self assessment cycle is completed • The peer review round is half way through • Take each network on a case by case basis • Essential to maintain the NSSGs

  4. The 2013/2014 Peer Review Cycle The programme will continue in 2013/2014. However, as a result of this transition with strategic clinical networks changes have been made to the programme. • Suspending the network board measures 1A (Some my move to the 1C or 1E measures) • Revisions but maintaining of site specific groups • Suspending some cross cutting network group measures • Partnership group • Complementary Therapy • Psychological Support (Integrate into 1C Measures) • Rehabilitation (Integrate into 1C Measures)

  5. The Proposed Recommendation for NSSGs • It is imperative that the functions of the NSSGs continue to exist and it is therefore recommended that NSSGs are retained for the foreseeable future. • The associate directors of the SCNs should be accountable to ensure that the NSSGs continue in the first instance on the cancer network footprint, using the already agreed 2012/13 cancer network funding. • From 1st April 2013 the associate director should establish support mechanisms for NSSGs using the SCN programme budget, including administrative and project support to enable meetings and the development of their work plans. • The NSSG work plan should be aligned to the overall SCN and senate work plan and be focussed on local priorities for improvement.

  6. The Proposed Recommended Future of NSSGs • Future funding of NSSGs for 2014/15 should be explored with the specialist commissioning programme of care lead for cancer as part of the national specification, on a similar basis to Operational Delivery Networks. Therefore the financial commitment of providers to working as part of a managed clinical network and the NSSG function would also need to be explored. These commitments would include provision of meeting rooms, attendance by clinicians and chairing of the group by a lead clinician. • As a minimum there should be representation from each MDT associated with the NSSG and mechanisms for patient/carer involvement. The group should meet at least twice a year. • The national cancer peer review measures should be revised to meet the outlined functions of the NSSG and enable more than one NSSG within the SCN where appropriate.

  7. Haematology Measures • These are to be published in February 2013 • Further editing required due to transition changes • Ready for Self-Assessment and Internal Validation Starting in April 2013. • Deadline for Internally Validated Self-Assessments will be the end of September 2013 • Targeted Visits in 2014/2015

  8. MVCN Progress for NSSGs 2012/2013

  9. MVCN Progress to date 2009/2010

  10. MVCN Progress to date 2010/2011

  11. MVCN Progress to date 2011/2012

  12. MVCN Progress to date 2012/2013

  13. Internal Governance Can internal governance be trusted? We are getting better, but we are not there yet.

  14. www.mycancertreatment.nhs.ukHaematology report will show on the system from September 2013.

  15. Step 1. Enter Your Location

  16. Step 2. Search for Cancer Type

  17. Step 3. Search for Hospital

  18. You have found the service, now you can chose to read the report or to compare the service with another

  19. Select the team and the report will be previewed

  20. Click here to view the full report

  21. The contents of the full report

  22. Select the icon to add this service to the comparison list

  23. Select the icon to see the comparison of up to Three services

  24. The Comparison Report

  25. The Comparison Report cont…

  26. Information Sources National Cancer Peer Review Programme Department of Health, for the National Patient Experience Survey results and Waiting Times For phase two, once available the Service Profiles we be incorporated into the reports, provided by National Cancer Intelligence Network (NCIN).

  27. Who we are working with… We are now working on a partnership agreement with MacMillan but would still very much like to work with all Cancer Charities.

More Related